Conte R, De Luca I, Valentino A, Cerruti P, Pedram P, Cabrera-Barjas G, et al
Liu, S., Fei, W., Shi, Q., Li, Q., Kuang, Y., Wang, C
In a nutshell People with type 2 diabetes taking semaglutide (Ozempic/Wegovy) showed up to 46% lower dementia risk compared to those on other diabetes medications The protective effects were strongest in younger adults under 65, women, and patients with obesity While promising, this observational study cant prove the drug prevents dementiamore research through clinical trials is needed CLEVELAND For millions of Americans taking Ozempic or Wegovy, there might be more good news coming
But is it actually worth it
You should be able to find a sweet spot where you feel great and dosage between 1-3mg daily
The best approach involves starting with a low dose (1mg weekly), slowly titrating upward every four weeks while your body adjusts, and combining the medication with adequate protein intake and consistent hydration